Farms.com Home   News

Canada's agriculture minister talks canola with Chinese counterpart at G20

TOKYO - Agriculture Minister Marie-Claude Bibeau briefly met with her Chinese counterpart, where she expressed Canada's concern with the suspension of canola exports to China over claims it is contaminated.
 
Both were attending the G20 Agriculture Ministers' Meeting in Japan on Monday.
 
A news release from the agriculture ministry says the two officials had "an introductory conversation on the margins of the G20," where Bibeau urged that the issue needs to be resolved quickly.
 
The release says Bibeau expressed that the Canadian government "stands firmly behind its robust inspection system and good reputation of being a reliable supplier of quality products worldwide."
 
China's rejection of Canadian food products is part of escalating tensions following the December arrest of a Huawei Technologies executive on a U.S. warrant alleging fraud.
 
Prime Minister Justin Trudeau also said last week that the decision by Beijing to ban Canadian canola is linked to the trade war between China and the U.S.
 
Trudeau said Canadian canola is "unimpeachable in terms of its quality" and China is using concerns over it "as an excuse to prolong what is fundamentally a conflict, not even with Canada, but between the two largest economies in the world."
Source : FCC

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.